Funding Opportunities
Supporting childhood cancer research and innovation
Every dollar invested by the Children’s Cancer CoLab must generate an improved outcome for childhood and adolescent cancer.
We use a sustainable research funding model with a competitive application process guided by scientific rigour. We prioritise rapid translation of research into new treatments for young patients, and also support the next generation of childhood cancer researchers and clinicians.
Five strategic Impact Programs guide our approach to funding childhood cancer research and innovation.
Next-Generation Therapies
Discover breakthrough therapies for hard-to-treat childhood cancers to improve survival outcomes for young patients.
Safer Therapies
Evaluate new therapies and models of care that minimise cancer treatment-related toxicities to improve long-term quality of life while maintaining survival outcomes for young patients.
.png)
Future Leaders
Foster emerging talents in researchers and clinicians to help Australia attract and retain the brightest minds in paediatric oncology.
Children’s Cancer CoLab and Maddie Riewoldt’s Vision Clinician-Researcher Fellowship
Enable a clinician-researcher to accelerate breakthroughs at the intersection of Bone Marrow Failure Syndromes and paediatric oncology.
Innovation Accelerators
Streamline resources and platforms to catalyse multidisciplinary collaboration across a broad range of sectors involved in childhood cancer, including research, clinical, industry, education, and charities.
Survivorship and Living Well
Develop and implement pioneering interventions that reduce the long-term impacts of cancer treatments on children’s growth, development and overall health.
.png)
Funding Timeline
Clinicians and researchers wanting to apply for a Children's Cancer CoLab grant are encouraged to join our mailing list for timely alerts about upcoming funding rounds and deadlines.
Stay informed on Funding Opportunities
Sign up to receive news when funding rounds open and other important funding announcements from the Children’s Cancer CoLab.